Mouse malignant T-lymphoma CS-21 cells can survive and proliferate in vitro when co-cultured with CA-I 2 stromal cells isolated from lymph nodes, but CS-2 I cells undergo apoptotic cell death with DNA fragmentation when cultured alone. We immunized rats with CS-2 I cells and raised monoclonal antibo
A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases
β Scribed by Chiu-Chen Huang; Yi-Fen Lu; Shi-Ni Wen; Wen-Chuan Hsieh; Yu-Chin Lin; Meng-Ru Liu; Evelyn Chiang; Chung-Nan Chang; Rong-Hwa Lin
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 387 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
β¦ Synopsis
We previously discovered a hamster monoclonal antibody, TAB4, against mouse PSGL-1/CD162 that can induce death of activated T cells. Here, we further investigated the potential of TAB4 in treating two murine models of T cell-mediated diseases. The results showed that administration of TAB4 suppressed incidence and severity of both GVHD and type I diabetes. Analyses of apoptotic T cells ex vivo shortly after antibody injection revealed a higher percentage of apoptosis among activated T cells in the TAB4-treated group than in the control group. Furthermore, restoration of functional donor T cells was observed in TAB4-treated mice. As TAB4 does not affect the binding of P-selectin to activated T cells, our data suggest that its long-lasting therapeutic effect on inhibiting disease progression is attained by specifically inducing apoptosis of activated T cells. These data hence extend our previous finding of the novel property of PSGL-1 and strongly indicate that the PSGL-1-specific apoptosis-inducing antibody is a new therapeutic agent possessing a great potential for controlling GVHD and other T cell-mediated autoimmune diseases.
π SIMILAR VOLUMES
In the presence of interleukin 2 (IL2), soluble anti-CD3 monoclonal antibodies can stimulate highly purified normal T lymphocytes to proliferate. In these experiments HLADR' T cells constituted 13 to 20% of the total cell population, and other HLADR' cells, such as monocytes and B lymphocytes, const
Epstein-Barr virus (EBV) can induce uncontrolled B lymphocyte proliferation leading to fatal lymphoma in immunocompromised patients. The sensitivity to apoptosis of B lymphoid cell lines (LCL) derived from EBV-induced lymphoproliferative disorders was investigated. In vitro and in vivo, these B LCL
## Abstract Tumor cells express tumorβassociated antigens (TAAs), which can serve as targets for the immune system. However, the majority of TAAs are overexpressed products of normal cellular genes; as such, selfβtolerance mechanisms have hindered their use for the induction of effective antitumor